Imperva's (IMPV) Sale Process Said on Hold - Bloomberg
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Imperva's (NYSE: IMPV) sale process is on hold, as potential suitors wait to see if the company's growth can improve enough to justify a higher price, according to a report from Bloomberg late on Tuesday. The report said expectations in terms of deal value have been raised given recovery in sales projections since pre-announcing disappointing second-quarter results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Johnson & Johnson (JNJ) Talks with Actelion Said to Progress After New Offer North of $250/Share - Bloomberg
- Exclusive: U.S. networking company Ixia explores sale - sources
- Ladder Capital (LADR) to Explore Sale - Reuters
Create E-mail Alert Related CategoriesHot M&A, Mergers and Acquisitions, Rumors
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!